OvaScience, Inc.
9 Fourth Avenue
Waltham, Massachusetts 02451
December 3, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
RE: OvaScience, Inc.
Registration Statement on Form S-3 File No. 333-228209
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
In accordance with Rule 461 promulgated under the Securities Act of 1933, as amended, OvaScience, Inc. (the Company) hereby requests acceleration of the effective date of the Registration Statement on Form S-3 (File No. 333-228209), as amended (the Registration Statement), so that it may become effective at 9:00 a.m., Washington, D.C. time on December 6, 2018, or as soon as possible thereafter.
The Company hereby authorizes Megan N. Gates, Esq. of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. to orally modify or withdraw this request for acceleration.
The Company respectfully requests that it be notified of such effectiveness by a telephone call to Ms. Gates at (617) 348-4443 and that such effectiveness also be confirmed in writing. Any questions regarding this request may be addressed to Ms. Gates.
|
Very truly yours, |
|
|
|
OVASCIENCE, INC. |
|
|
|
/s/ Jonathan Gillis |
|
Jonathan Gillis |
|
Senior Vice President, Finance |
cc: |
OvaScience, Inc. |
|
Christopher A. Kroeger., M.D., M.B.A., President and Chief Executive Officer |
|
|
|
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. |
|
William C. Hicks, Esq. |
|
Megan N. Gates, Esq. |
|
Daniel A. Bagliebter, Esq. |
|
|
|
Cooley, LLP |
|
Miguel J. Vega, Esq. |
|
Nicole Brookshire, Esq. |